![Henrik Olsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henrik Olsen
Corporate Officer/Principal bij Gliknik, Inc.
Actieve functies van Henrik Olsen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Gliknik, Inc.
![]() Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | - | - |
Loopbaan van Henrik Olsen
Eerdere bekende functies van Henrik Olsen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Henrik Olsen
University of Aarhus | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 3 |
Denemarken | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Gliknik, Inc.
![]() Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Health Technology |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
- Beurs
- Insiders
- Henrik Olsen
- Ervaring